Wednesday February 20, 2019
Home World While visitin...

While visiting house of her alleged attacker, Transgender Deedar shot in Pakistan

The president of Shemale Association of Khyber Pakhtunkhwa, Farzana, demanded protection for her community and added that they felt insecure

0
//
Image used for representational purpose. Image source: Wikimedia Commons

Islamabad, Sept 11, 2016: A transgender was shot and injured on Saturday in Pakistan’s Peshawar city, police said.

Police identified the victim as Deedar. Doctors at the hospital said her life is not in danger, Dawn online reported.

“She was shot in the arm, we provided initial treatment in the emergency department and later shifted her to the surgical ward,” said a senior doctor of Khyber Teaching Hospital (KTH).

A large crowd of transgenders gathered at KTH following the incident.

Deedar told Dawn News that she was visiting the house of her alleged attacker, Shahid, for her money which was loaned to him when she was attacked.

Follow NewsGram on Twitter

She said that Shahid not only refused to return the loan, but also subjected her to torture.

The president of Shemale Association of Khyber Pakhtunkhwa, Farzana, demanded protection for her community and added that they felt insecure.

Follow NewsGram on Facebook

This is the sixth reported case of violence against trans people in Khyber Pakhtunkhwa this year.

Earlier this year, transgender Alisha who was shot eight times allegedly by a disgruntled customer succumbed to her wounds at Peshawar’s Lady Reading Hospital (LRH). (IANS)

Next Story

Patients Going Through Gender-Transition Treatment At A Grater Risk Of Cardiac Diseases

Researchers determined and compared the incidence of CVD cases in the transgender population with that reported in the general population. 

0
transgender
On the other hand, transmen -- those assigned female sex at birth but had male gender identity and received hormones -- had a more than three-fold rise in heart-attack risk compared with women, said the study, published in the journal, Circulation. Pixabay

Patients receiving hormone therapy as part of their gender-transition treatment have an elevated risk of cardiovascular diseases (CVD), including heart attacks, strokes and blood clotting, researchers say.

Researchers determined and compared the incidence of CVD cases in the transgender population with that reported in the general population.

The study showed that transwomen — individuals, assigned male sex at birth but with female gender identity, receiving hormones as part of their transition — had more than twice as many strokes as women and nearly twice as many strokes as men.

transgender

Heart attacks occurred at more than twice the rate among transwomen than women. Pixabay

In addition, there were five times as many blood clotting among transwomen than women and 4.5 times more than men.

Heart attacks occurred at more than twice the rate among transwomen than women.

On the other hand, transmen — those assigned female sex at birth but had male gender identity and received hormones — had a more than three-fold rise in heart-attack risk compared with women, said the study, published in the journal, Circulation.

man
In addition, there were five times as many blood clotting among transwomen than women and 4.5 times more than men. 
Pixabay

“In the light of our results, we urge both physicians and transgender individuals to be aware of this increased cardiovascular risk,” said Nienke Nota, researcher at the Amsterdam University Medical Center in the Netherlands.

Also Read: Push-ups Can Lower The Risk of Heart Diseases

“It may be helpful to reduce the risk factors by stopping smoking, exercising, eating a healthy diet and losing weight, if needed before starting therapy, and clinicians should continue to evaluate patients on an ongoing basis thereafter,” suggested Nota.

For the study, the researchers included 3,875 individuals who had received hormone treatment — 2,517 transgender women received estrogen, with or without androgen-suppressors, and 1,358 transgender men received testosterone — as part of their transition. (IANS)